pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 1032
- Drugs
- 612
- Patents
- 3720
Anti-CD40 Agonist Monoclonal Antibody CDX-1140
Phase 2 · mab · Ovarian Clear Cell Adenocarcinoma
Anti-CD40 Agonist Monoclonal Antibody CDX-1140 for Ovarian Clear Cell Adenocarcinoma is a Phase 2 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Internal code I 1277721
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- United Therapeutics Europe Ltd
- Phase
- Phase 2
- Modality
- mab
- Indication
- Ovarian Clear Cell Adenocarcinoma
- Status
- active
- Trials
- 1